Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2002
07/18/2002WO2001085798A3 Human monoclonal antibodies to dendritic cells
07/18/2002WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods
07/18/2002WO2001085788A3 Human ion channels
07/18/2002WO2001085783A3 Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof
07/18/2002WO2001083792A3 Enhanced gene expression in plants using transcription factors
07/18/2002WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
07/18/2002WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents
07/18/2002WO2001083518A3 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
07/18/2002WO2001081547A3 Identification, cloning and characterization of a novel pc-1 gene differentially expressed in prostate cells and tissues
07/18/2002WO2001081544A3 Identification and uses of a hyaluronan receptor
07/18/2002WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
07/18/2002WO2001081377A3 Integrin/adhesion antagonists
07/18/2002WO2001079282A3 Molecules associated with human reproduction
07/18/2002WO2001079273A3 Viruses comprising mutated ion channel protein
07/18/2002WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof
07/18/2002WO2001072783A3 Production of secreted proteins by recombinant eukaryotic cells
07/18/2002WO2001071359A3 Methods for identifying and isolating tissue-specific lumen-exposed molecules
07/18/2002WO2001068839A9 Regulation of human lipoxin a4 receptor-like protein
07/18/2002WO2001068705A3 Il-17 receptor like molecules and uses thereof
07/18/2002WO2001066747A3 Proteins named fctrx and nucleic acids encoding same
07/18/2002WO2001062920A3 Compositions and methods for diagnosis and therapy of malignant mesothelioma
07/18/2002WO2001061019A9 A dominant selectable marker for gene transformation and disruption in yeasts
07/18/2002WO2001058461A9 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof
07/18/2002WO2001055366A9 T cell receptor libraries
07/18/2002WO2001055309A3 Nucleic acids, proteins, and antibodies
07/18/2002WO2001055304A3 Nucleic acids, proteins, and antibodies
07/18/2002WO2001051520A9 Nogo receptor-mediated blockade of axonal growth
07/18/2002WO2001051517A9 Candida hemolysin - like proteins and their uses
07/18/2002WO2001040493A3 Schizophrenia associated gene, proteins and biallelic markers
07/18/2002WO2001036477A3 Inhibition of abc transporters by transmembrane domain analogs
07/18/2002WO2001012668A9 Cathelicidin-derived peptides with broad spectrum antimicrobial activity
07/18/2002WO2001009326A9 Constitutively active stat proteins and their uses for identifying modulators of activity including dysproliferative cellular changes
07/18/2002WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14
07/18/2002WO2000078972A9 Regulation with binding cassette transporter protein abc1
07/18/2002US20020095694 Nucleotide sequences coding polypeptide for use in generating disease resistant plants
07/18/2002US20020095693 Animal model for use in the treatment of eating disorders
07/18/2002US20020095692 Viral polypeptide for use in the treatment and prevention of viral diseases
07/18/2002US20020095030 Nucleotide sequences coding preferfential polypeptides for use in the treatment of apotosis defects
07/18/2002US20020095027 Polypeptide for use in the diagnosis and treatment of viral diseases in animals
07/18/2002US20020095025 Isolation and uses of caveolae
07/18/2002US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation
07/18/2002US20020095023 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects
07/18/2002US20020095022 Polypeptide for use in the treatment of cancer and sexual disorders
07/18/2002US20020094966 Inhibition of the gene expression or biological activity of the 88 KDa glycoprotein autocrine growth and tumorigenicity stimulator by antisense oligonucleotides and neutralizing antibodies; antitumor, -carcinogenic agents
07/18/2002US20020094965 Purified and isolated polynucleotide molecules that encode the Chlamydia polypeptides designated glutamate binding protein which can be used in methods to prevent, treat, and diagnose Chlamydia pneumoniae; vaccines
07/18/2002US20020094957 Inhibits the polymerization of amyloid beta peptide; treating or preventing amyloidosis
07/18/2002US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies
07/18/2002US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1)
07/18/2002US20020094952 Human therapeutic uses of BPI Protein products
07/18/2002US20020094576 Material and methods relating to a novel retrovirus
07/18/2002US20020094571 Hypoxia-mediated neurogenesis
07/18/2002US20020094558 Nuclelotide sequences coding membrane protein for use in human therapeutics and diagnostics
07/18/2002US20020094552 Rickettsia felis outer membrane protein
07/18/2002US20020094551 T2R taste receptors and genes ecncoding same
07/18/2002US20020094546 Detecting platelet derived growth factor in sample; obtain sample, incubate with preferential binding agent, detect bound antigen
07/18/2002US20020094541 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
07/18/2002US20020094540 N-TRADD active site and uses thereof
07/18/2002US20020094530 Method to identify antibody targets
07/18/2002US20020094526 Biosensor compositions and methods of use
07/18/2002US20020094523 Chimeric retroviral gag genes and screening assays
07/18/2002US20020094522 Evaluating effectiveness of viral therapy; obtain blood from virally infected human, incubate with delavirdine, nevirapine or efavirenz, monitor viral activity
07/18/2002US20020094514 Genetically engineered tissue for use cancer treatment
07/18/2002US20020094340 Chlamydia antigens and corresponding dna thereof
07/18/2002US20020094337 Prevention of recurrent viral disease
07/18/2002US20020094336 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
07/18/2002US20020094335 Treating amyloid-related disease in subject by administering antigenic amount of all-D peptide, wherein peptide elicits production of antibodies against peptide and induces an immune response
07/18/2002US20020094329 B.subtilis, wherein one or more genes involved in the biosynthesis of isovaleric acids have been modified such that the strain cannot produce substantial amounts of isovaleric acids; improved food flavors
07/18/2002US20020092539 Hair clip
07/18/2002DE10101266A1 System for overexpressing cold-adapted enzymes, useful for food processing, includes expression control sequence comprising promoter and ribosome-binding site
07/18/2002DE10100761A1 Reactive dye mixtures used for staining biopolymer containing hydroxyl and/or amino groups, preferably optionally modified nucleic acid, contain vinylsulfonyl-substituted azo dye and anthraquinone and/or sulfonated phthalocyanine dye
07/18/2002DE10100280A1 DNA-Sequenzen, codierend für ein Apoptose-Signaltransduktionsprotein DNA sequences encoding an apoptosis-Signaltransduktionsprotein
07/18/2002DE10059631A1 T-Zellepitope des Papillomavirus L1-und E7-Proteins und ihre Verwendung in Diagnostik und Therapie T cell epitopes of the papillomavirus L1 and E7 protein and their use in diagnostics and therapy
07/18/2002CA2776023A1 Fumaric acid amides
07/18/2002CA2697520A1 Use of lyophilised reduced diaminophenothiazines in the treatment of tau mediated neurological disorders
07/18/2002CA2443800A1 Rice sucrose transporter gene promoter
07/18/2002CA2436876A1 Transcriptional mediators of blood vessel development and endothelial differentiation
07/18/2002CA2435874A1 Systems for expression of heterologous proteins in m. capsulatus
07/18/2002CA2434739A1 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis
07/18/2002CA2434672A1 Sfrp and peptide motifs that interact with sfrp and methods of their use
07/18/2002CA2434567A1 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
07/18/2002CA2434431A1 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
07/18/2002CA2434402A1 Modular transfection systems
07/18/2002CA2434399A1 Method for processing dendritic cells and for activating macrophages with ru 41740
07/18/2002CA2434269A1 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
07/18/2002CA2434042A1 Asip-related proteins
07/18/2002CA2433954A1 Compositions and methods for regulating receptor clustering
07/18/2002CA2433753A1 Molecules for disease detection and treatment
07/18/2002CA2433742A1 Proteins and nucleic acids encoding same
07/18/2002CA2433740A1 Human glioma antigen and process for preparing the same
07/18/2002CA2433692A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
07/18/2002CA2433689A1 Process to concentrate insoluble proteins by vibrating membrane filtration
07/18/2002CA2433687A1 Soluble cyclic analogues of beta amyloid peptide
07/18/2002CA2433449A1 Metabolic gene polynucleotides and polypeptides and uses thereof
07/18/2002CA2432883A1 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
07/18/2002CA2430794A1 Human genes and gene expression products isolated from human prostate
07/18/2002CA2430060A1 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
07/18/2002CA2427840A1 Methods of using imxp-888 and imxp-888 antagonists
07/18/2002CA2426597A1 Rhodococcus cloning and expression vectors
07/18/2002CA2426588A1 Novel human proteins, polynucleotides encoding them and methods of using the same
07/18/2002CA2426163A1 Identification and characterization of an anthocyanin mutant (ant1) in tomato